The Patent Finder

Oscient Pharmaceuticals Corporation

Also on record
Records under this name other than patents Oscient Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Oscient Pharmaceuticals Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,026,281Treating metabolic syndrome with fenofibrate
Formerly held
Term ended
Term ended Apr 22, 2025 · USPTO record
Term endedTerm ended Apr 22, 2025USPTO record
US 7,317,001Use of Ramoplanin to Treat Diseases Associated with the Use of Antibiotics
Formerly held
Term ended
Term ended Dec 21, 2024 · High confidence
Term endedTerm ended Dec 21, 2024High confidence
US 6,720,305Injectable Formulations Containing Ramoplanin
Formerly held
Term ended
Term ended Jul 19, 2019 · High confidence
Term endedTerm ended Jul 19, 2019High confidence
US 8,907,067Nucleotide and Amino Acid Sequences Relating to Respiratory Diseases and Obesity
No holder on record
Lapsed on the fee record
Ended Dec 9, 2018 · Medium confidence
Lapsed on the fee recordEnded Dec 9, 2018Medium confidence
US 7,501,118Novel Human Gene Relating to Respiratory Diseases and Obesity
No holder on record
Lapsed on the fee record
Ended Mar 10, 2017 · Medium confidence
Lapsed on the fee recordEnded Mar 10, 2017Medium confidence
US 7,407,804Novel Human Genes Relating to Respiratory Diseases and Obesity
Lapsed on the fee record
Ended Aug 5, 2016 · Low confidence
Lapsed on the fee recordEnded Aug 5, 2016Low confidence
US 6,737,519Human genes relating to respiratory diseases and obesity
Lapsed on the fee record
Ended May 18, 2016 · USPTO record
Lapsed on the fee recordEnded May 18, 2016USPTO record
US 8,124,734Novel Human Genes Relating to Respiratory Diseases and Obesity
No holder on record
Lapsed on the fee record
Ended Feb 28, 2016 · Medium confidence
Lapsed on the fee recordEnded Feb 28, 2016Medium confidence
US 8,105,826Nucleotide and Amino Acid Sequences Relating to Respiratory Diseases and Obesity
No holder on record
Lapsed on the fee record
Ended Jan 31, 2016 · Medium confidence
Lapsed on the fee recordEnded Jan 31, 2016Medium confidence
US 7,928,200Novel Human Genes Relating to Respiratory Diseases and Obesity
No holder on record
Lapsed on the fee record
Ended Apr 19, 2015 · Medium confidence
Lapsed on the fee recordEnded Apr 19, 2015Medium confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited